Showing results (1931-1940 of 2,019) with videos related to

Sort By:
Pageof 202
Cell Host & Microbe|October 18, 2025
Evolution of antibody cross-reactivity to influenza H5N1 neuraminidase from an N2-specific germlineHuibin Lv, Yang Wei Huan, Qi Wen Teo, et al.
Molecular Cancer Therapeutics|May 23, 2024
PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast CancerAnran Chen, Beom-Jun Kim, Aparna Mitra, et al.
Breast Cancer Research and Treatment|December 18, 2012
A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancerCynthia X Ma, Matthew J C Ellis, Gina R Petroni, et al.
Progress in Community Health Partnerships : Research, Education, and Action|July 28, 2015
The National Cancer Institute's Community Networks Program Initiative to Reduce Cancer Health Disparities: Outcomes and Lessons LearnedKathryn L Braun, Susan Stewart, Claudia Baquet, et al.
Molecular Psychiatry|December 7, 2016
Common variants on 2p16.1, 6p22.1 and 10q24.32 are associated with schizophrenia in Han Chinese populationH Yu, H Yan, J Li, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|January 19, 2025
[Distribution characteristics and heritability of alcohol consumption behavior in adult twins in China]Y C Li, W J Gao, W H Cao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2023
Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor-Positive (HR+)/HER2-Negative Metastatic Breast CancerAndrew A Davis, Jingqin Luo, Tiantian Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified Metastatic Breast CancerCynthia X Ma, Jingqin Luo, Rachel A Freedman, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Structural insights into antibody responses against influenza A virus in its natural reservoirHuibin Lv, Walter N Harrington, Wenkan Liu, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|December 21, 2021
[Twelve-week of sofosbuvir/velpatasvir therapeutic regimen for chronic hepatitis C patients in northwest region of China: a real-world multicenter clinical study]Q Xu, W Zhang, Y X Ma, et al.
Pageof 202